Two Sigma Advisers’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-900	Closed	-$261K	–	2681
2022 Q4	$261K	Buy	+900	New	+$88K	﹤0.01%	2112
2022 Q2	–	Sell	-2,982	Closed	-$293K	–	2797
2022 Q1	$293K	Sell	2,982 -2,200	-42%	-$185K	﹤0.01%	2227
2021 Q4	$439K	Sell	5,182 -30,458	-85%	-$2.5M	﹤0.01%	1973
2021 Q3	$2.84M	Sell	35,640 -49,300	-58%	-$4.26M	0.01%	1064
2021 Q2	$8.27M	Sell	84,940 -30,900	-27%	-$3.66M	0.02%	644
2021 Q1	$13.6M	Buy	115,840 +76,300	+193%	+$8.9M	0.04%	466
2020 Q4	$4.4M	Buy	39,540 +21,000	+113%	+$2.57M	0.01%	877
2020 Q3	$2.2M	Buy	18,540 +6,342	+52%	+$689K	0.01%	1113
2020 Q2	$1.38M	Buy	+12,198	New	+$1.2M	﹤0.01%	1413
2019 Q1	–	Sell	-19,698	Closed	-$2.22M	–	2387
2018 Q4	$2.22M	Buy	19,698 +11,789	+149%	+$1.82M	0.01%	1130
2018 Q3	$1.69M	Buy	7,909 +700	+10%	+$176K	﹤0.01%	1308
2018 Q2	$2.02M	Buy	7,209 +400	+6%	+$70.2K	0.01%	1287
2018 Q1	$795K	Buy	+6,809	New	+$841K	﹤0.01%	1643
2016 Q2	–	Sell	-785	Closed	-$7K	–	2136
2016 Q1	$7K	Sell	785 -5,981	-88%	-$50K	﹤0.01%	2014
2015 Q4	$83K	Buy	+6,766	New	+$186K	﹤0.01%	1787